Product Information
GLP-1 is an investigational peptide being studied for its activity across three metabolic hormone receptor pathways: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
Its multi-receptor activity has made it an important compound in ongoing metabolic and endocrine research. GLP-1 remains under clinical investigation and has not been approved by the FDA for general therapeutic use.
The GLP-1 5mg product is supplied in a lyophilized format to support controlled laboratory handling, storage, and experimental applications. Researchers should follow appropriate laboratory protocols and applicable regulations when handling research peptides.
| Specification | Details |
|---|---|
| Product Name | GLP-1 5mg |
| Research Category | Metabolic Research Peptide |
| Format | Lyophilized Peptide |
| Vial Content | 5mg |
| Research Target | GIP / GLP-1 / Glucagon Receptor Pathways |
| Compound Type | Triple Receptor Agonist |
| Development Status | Investigational |
| Storage | Store according to supplied product handling instructions |
| Intended Use | Laboratory and Research Use Only |
| Human Use | Not for Human Consumption |
| Regulatory Status | Not FDA Approved |
Specification
Value
Product Name:
N/A
Compound Type:
N/A
CAS Number:
N/A
PubChem CID:
N/A
Molecular Formula:
N/A
Molecular Weight (g/mol):
N/A
Amino Acid Count:
N/A
Amino Acid Sequence:
N/A
Synonyms / Other Names:
N/A
Appearance:
N/A
Purity:
N/A
Solubility:
N/A
Storage — Sealed:
N/A
Storage — After Reconstitution:
N/A
